ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2020
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street futures edge lower after AI selloff, telecom slide
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on concern over Middle East escalation
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
ResMed (RMD) Tops Q3 EPS by 25c, Revenues Beat
April 30, 2020 4:44 PM EDTResMed (NYSE: RMD) reported Q3 EPS of $1.29, $0.25 better than the analyst estimate of $1.04. Revenue for the quarter came in at $769.5 million versus the consensus estimate of $722.52 million.
Third Quarter 2020 Highlights
Year-over-year revenue grows 16%, non-GAAP operating profit up 31%Balanced growth across product portfolio, software solutions, and global marketsFocused on combating COVID-19 pandemic through increased ventilator production and ongoing partnership and support of key global stakeholdersAll comparisons are to the prior-year period
Revenue increased 16% to $769.5 million; up 17% on a constant currency basisGAAP... More


